Intellia Therapeutics Inc (NTLA)
11.91
-0.56
(-4.49%)
USD |
NASDAQ |
Jan 08, 12:44
Intellia Therapeutics Profit Margin (Quarterly): -1.49K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 36.03% |
| BridgeBio Pharma Inc | -5.93K% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.05% |
| Xtant Medical Holdings Inc | -17.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.64% |
| Return on Assets | -42.33% |
| Return on Invested Capital | -51.64% |
| Operating Margin (Quarterly) | -1.59K% |
| Return on Net Operating Assets | -323.0% |